Biosimilars: Approval Process

  Рет қаралды 10,192

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

The abbreviated approval pathway for biosimilars was created to help reduce the time and cost of development of biologics without compromising safety and effectiveness. This video provides an overview of the biosimilar development program and the FDA’s rigourous standards for approval. For more information, visit www.FDA.gov/biosimilars.

Пікірлер
Biosimilars: Critical Quality Attributes
3:12
U.S. Food and Drug Administration
Рет қаралды 8 М.
The Basics of Biosimilars
4:12
U.S. Food and Drug Administration
Рет қаралды 70 М.
번쩍번쩍 거리는 입
0:32
승비니 Seungbini
Рет қаралды 182 МЛН
The Biosimilar Development Process
4:20
U.S. Food and Drug Administration
Рет қаралды 37 М.
Data Requirements for Biosimilars
5:20
U.S. Food and Drug Administration
Рет қаралды 27 М.
Biosimilars: Manufacturing and Inherent Variation
3:33
U.S. Food and Drug Administration
Рет қаралды 15 М.
The Concept of Interchangeability
4:20
U.S. Food and Drug Administration
Рет қаралды 23 М.
Biomarker Terminology: Speaking the Same Language
5:33
U.S. Food and Drug Administration
Рет қаралды 20 М.
FDA Clinical Investigator Training Course (CITC) 2024 - Day One - Session Two
1:42:25
U.S. Food and Drug Administration
Рет қаралды 593
How is My Medical Device Classified?
16:18
U.S. Food and Drug Administration
Рет қаралды 17 М.
The Promise of Biosimilars
3:07
U.S. Food and Drug Administration
Рет қаралды 20 М.
How does the FDA approve new drugs?
3:17
U.S. Food and Drug Administration
Рет қаралды 59 М.
FDA Drug Info Rounds, July 2012: Accelerated Approval Program
3:44
U.S. Food and Drug Administration
Рет қаралды 18 М.